Multiple quantitative trait loci modify the heart failure phenotype in murine cardiomyopathy

Human Molecular Genetics

Volumn 12, Issue 23, 2003, Pages 3097-3107

  Le Corvoisier, Philippe ^a   Park, Hyun Young ^a   Carlson, Kerri M ^a   Marchuk, Douglas A ^a   Rockman, Howard A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALSEQUESTRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CHROMOSOME 18; CHROMOSOME 4; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC VARIABILITY; GENETICS; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE SIZE; MALE; MOUSE; NONHUMAN; OUTCOMES RESEARCH; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; SCORING SYSTEM; STATISTICAL ANALYSIS; STRAIN DIFFERENCE; SURVIVAL RATE;

ANIMALS; CALSEQUESTRIN; CARDIOMYOPATHY, DILATED; CHROMOSOME MAPPING; CROSSES, GENETIC; FEMALE; HEART FAILURE, CONGESTIVE; LOD SCORE; MALE; MICE; PHENOTYPE; QUANTITATIVE TRAIT LOCI; SURVIVAL ANALYSIS;

ANIMALIA; MURINAE;

EID: 0347506032     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg333     Document Type: Article

References (47)

1. Hunt, S.A., Baker, D.W., Chin, M.H., Cinquegrani, M.P., Feldmanmd, A.M., Francis, G.S., Ganiats, T.G., Goldstein, S., Gregoratos, G., Jessup, M.L. et al. (2001) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation, 104, 2996-3007.
2. MacIntyre, K., Capewell, S., Stewart, S., Chalmers, J.W., Boyd, J., Finlayson, A., Redpath, A., Pell, J.P. and McMurray, J.J. (2000) Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation, 102, 1126-1131.
3. Borjesson, M., Magnusson, Y., Hjalmarson, A. and Andersson, B. (2000) A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur. Heart J., 21, 1853-1858.
4. Liggett, S.B., Wagoner, L.E., Craft, L.L., Hornung, R.W., Hoit, B.D., McIntosh, T.C. and Walsh, R.A. (1998) The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J. Clin. Invest., 102, 1534-1539.
5. Andersson, B. and Sylven, C. (1996) The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J. Am. Coll. Cardiol., 28, 162-167.
6. McNamara, D.M., Holubkov, R., Janosko, K., Palmer, A., Wang, J.J., MacGowan, G.A., Murali, S., Rosenblum, W.D., London, B. and Feldman, A.M. (2001) Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation, 103, 1644-1648.
7. Herrmann, S., Schmidt-Petersen, K., Pfeifer, J., Perrot, A., Bit-Avragim, N., Eichhorn, C., Dietz, R., Kreutz, R., Paul, M. and Osterziel, K.J. (2001) A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy. Eur. Heart J., 22, 1948-1953.
8. Loh, E., Rebbeck, T.R., Mahoney, P.D., DeNofrio, D., Swain, J.L. and Holmes, E.W. (1999) Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation, 99, 1422-1425.
9. Suzuki, M., Carlson, K.M., Marchuk, D.A. and Rockman, H.A. (2002) Genetic modifier loci affecting survival and cardiac function in murine dilated cardiomyopathy. Circulation, 105, 1824-1829.
10. Nadeau, J.H. (2001) Modifier genes in mice and humans. Nat. Rev. Genet., 2, 165-174.
11. Montagutelli, X. (2000) Effect of the genetic background on the phenotype of mouse mutations. J Am. Soc. Nephrol., 11 (Suppl. 16), S101-S105.
12. Culverhouse, R., Suarez, B.K., Lin, J. and Reich, T. (2002) A perspective on epistasis: limits of models displaying no main effect. Am. J. Hum. Genet., 70, 461-471.
13. Dempsey, A.A., Dzau, V.J. and Liew, C.C. (2001) Cardiovascular genomics: estimating the total number of genes expressed in the human cardiovascular system. J. Mol. Cell. Cardiol., 33, 1879-1886.
14. Darvasi, A. and Pisante-Shalom, A. (2002) Complexities in the genetic dissection of quantitative trait loci. Trends Genet., 18, 489-491.
15. Durand, J.B., Bachinski, L.L., Bieling, L.C., Czernuszewicz, G.Z., Abchee, A.B., Yu, Q.T., Tapscott, T., Hill, R., Ifegwu, J., Marian, A.J. et al. (1995) Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation, 92, 3387-3389.
16. Kantachuvesiri, S., Haley, C.S., Fleming, S., Kurian, K., Whitworth, C.E., Wenham, P., Kotelevtsev, Y. and Mullins, J.J. (1999) Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 rats. Kidney Int., 56, 414-420.
17. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J. Clin. Invest., 101, 1385-1393.
18. Towbin, J.A. and Bowles, N.E. (2002) The failing heart. Nature, 415, 227-233.
19. Upadhya, P., Churchill, G., Birkenmeier, E.H., Barker, J.E. and Frankel, W.N. (1999) Genetic modifiers of polycystic kidney disease in intersubspecific KAT2J mutants. Genomics, 58, 129-137.
20. Sugiyama, F., Churchill, G.A., Li, R., Libby, L.J., Carver, T., Yagami, K., John, S.W. and Paigen, B. (2002) QTL associated with blood pressure, heart rate, and heart weight in CBA/CaJ and BALB/cJ mice. Physiol. Genomics, 10, 5-12.
21. Small, K.M., Wagoner, L.E., Levin, A.M., Kardia, S.L. and Liggett, S.B. (2002) Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. New Engl. J. Med., 347, 1135-1142.
22. Poole-Wilson, P.A., Uretsky, B.F., Thygesen, K., Cleland, J.G., Massie, B.M. and Ryden, L. (2003) Mode of death in heart failure: findings from the ATLAS trial. Heart, 89, 42-48.
23. Cleland, J.G., Chattopadhyay, S., Khand, A., Houghton, T. and Kaye, G.C. (2002) Prevalence and incidence of arrhythmias and sudden death in heart failure. Heart Fail. Rev., 7, 229-242.
24. Knollmann, B.C., Knollmann-Ritschel, B.E., Weissman, N.J., Jones, L.R. and Morad, M. (2000) Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin. J. Physiol., 525(Pt 2), 483-498.
25. Napolitano, C. and Priori, S.G. (2002) Genetics of ventricular tachycardia. Curr. Opin. Cardiol., 17, 222-228.
26. Pfeffer, M.A., Braunwald, E., Moye, L.A., Basta, L., Brown, E.J., Jr., Cuddy, T.E., Davis, B.R., Geltman, E.M., Goldman, S., Flaker, G.C. et al. (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. New Engl. J. Med., 327, 669-677.
27. Rockman, H.A., Chien, K.R., Choi, D.J., Iaccarino, G., Hunter, J.J., Ross, J., Jr., Lefkowitz, R.J. and Koch, W.J. (1998) Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc. Natl Acad. Sci. USA, 95, 7000-7005.
28. Flint, J. and Mott, R. (2001) Finding the molecular basis of quantitative traits: successes and pitfalls. Nat. Rev. Genet., 2, 437-445.
29. Glazier, A.M., Nadeau, J.H. and Aitman, T.J. (2002) Finding genes that underlie complex traits. Science, 298, 2345-2349.
30. Nebert, D.W., Dalton, T.P., Stuart, G.W. and Carvan, M.J. III (2000) 'Gene-swap knock-in' cassette in mice to study allelic differences in human genes. Ann. NY Acad. Sci., 919, 148-170.
31. Lyons, P.A., Armitage, N., Argentina, F., Denny, P., Hill, N.J., Lord, C.J., Wilusz, M.B., Peterson, L.B., Wicker, L.S. and Todd, J.A. (2000) Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res., 10, 446-453.
32. Yujiri, T., Sather, S., Fanger, G.R. and Johnson, G.L. (1998) Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science, 282, 1911-1914.
33. Minamino, T., Yujiri, T., Terada, N., Taffet, G.E., Michael, L.H., Johnson, G.L. and Schneider, M.D. (2002) MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq. Proc. Natl Acad. Sci. USA, 99, 3866-3871.
34. Prestle, J., Dieterich, S., Preuss, M., Bieligk, U. and Hasenfuss, G. (1999) Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc. Res., 43, 323-331.
35. Cho, M.C., Rapacciuolo, A., Koch, W.J., Kobayashi, Y., Jones, L.R. and Rockman, H.A. (1999) Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression. J. Biol. Chem., 274, 22251-22256.
36. Lahat, H., Pras, E., Olender, T., Avidan, N., Ben-Asher, E., Man, O., Levy-Nissenbaum, E., Khoury, A., Lorber, A., Goldman, B. et al. (2001) A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am. J. Hum. Genet., 69, 1378-1384.
37. Shah, A.S., White, D.C., Emani, S., Kypson, A.P., Lilly, R.E., Wilson, K., Glower, D.D., Lefkowitz, R.J. and Koch, W.J. (2001) In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction. Circulation, 103, 1311-1316.
38. Esposito, G., Rapacciuolo, A., Naga Prasad, S.V., Takaoka, H., Thomas, S.A., Koch, W.J. and Rockman, H.A. (2002) Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation, 105, 85-92.
39. Lander, E.S. and Botstein, D. (1989) Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics, 121, 185-199.
40. Schmidt, A.G., Kadambi, V.J., Ball, N., Sato, Y., Walsh, R.A., Kranias, E.G. and Hoit, B.D. (2000) Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation and pulsus alternans in vivo. J. Mol. Cell. Cardiol., 32, 1735-1744.
41. Sebkhi, A., Zhao, L., Lu, L., Haley, C.S., Nunez, D.J. and Wilkins, M.R. (1999) Genetic determination of cardiac mass in normotensive rats: results from an F344 × WKY cross. Hypertension, 33, 949-953.
42. Darvasi, A. (1997) The effect of selective genotyping on QTL mapping accuracy. Mamm. Genome, 8, 67-68.
43. Haley, C.S. and Knott, S.A. (1992) A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity, 69, 315-324.
44. Manly, K.F. and Olson, J.M. (1999) Overview of QTL mapping software and introduction to map manager QT. Mamm. Genome, 10, 327-334.
45. Piepho, H.P. (2001) A quick method for computing approximate thresholds for quantitative trait loci detection. Genetics, 157, 425-432.
46. Tsujita, Y., Iwai, N., Tamaki, S., Nakamura, Y., Nishimura, M. and Kinoshita, M. (2000) Genetic mapping of quantitative trait loci influencing left ventricular mass in rats. Am. J. Physiol. Heart Circul. Physiol., 279, H2062-H2067.
47. Cordell, H.J. (2002) Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum. Mol. Genet., 11, 2463-2468.